Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 3.25% | 311.29 | 0.0% | $5240.07m | |
| BNTX | BioNTech SE | 3.26% | 344.35 | 0.0% | $1582.65m | |
| NVAX | Novavax, Inc. | -0.65% | 160.91 | 78.2% | $851.92m | |
| AMGN | Amgen, Inc. | 0.49% | 202.16 | 1.4% | $596.16m | |
| GILD | Gilead Sciences, Inc. | -0.24% | 69.51 | 1.0% | $508.61m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -0.82% | 202.78 | 1.9% | $475.09m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.10% | 627.03 | 2.7% | $468.82m | |
| LGVN | Longeveron Inc. | 17.89% | 21.22 | 0.0% | $423.19m | |
| ILMN | Illumina, Inc. | -3.12% | 346.33 | 3.3% | $315.11m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | -2.57% | 4.17 | 0.7% | $291.50m | |
| BIIB | Biogen, Inc. | -2.47% | 222.87 | 1.8% | $272.09m | |
| OCGN | Ocugen, Inc. | -9.19% | 5.73 | 0.0% | $192.28m | |
| INCY | Incyte Corp. | -1.44% | 65.67 | 2.4% | $153.98m | |
| EXAS | EXACT Sciences Corp. | -5.37% | 76.25 | 18.0% | $147.69m | |
| SGEN | Seagen Inc. | -4.92% | 150.86 | 5.8% | $143.94m |
Company Profile
PTC Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and commercialization of clinically differentiated medicines. It focuses on the development of new treatments for multiple therapeutic areas, including rare diseases and oncology. The firm's portfolio includes Translarna, Emflaza, Tegsedi, Waylivra, and Evrysdi. The company was founded by Allan Steven Jacobson and Stuart W. Peltz on March 31, 1998 and is headquartered in South Plainfield, NJ.